Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Giovanni Crisafulli

Università degli Studi di Torino

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy Professors in Cell Biology Cell Biology professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (7)

Giorgio Patelli

Medical Oncologist

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

ITALY

View details

Mariangela Russo

Associate Professor

University of Turin

ITALY

View details

veerle melotte

University of Maastricht

NETHERLANDS

View details

Valeria Pessei

Candiolo Cancer Institute

ITALY

View details

Sabrina ARENA

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

SARA LAGO

Università degli Studi di Torino

ITALY

View details

Alberto Bardelli

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giovanni Crisafulli

Research Interests

Make your next move.

Explore related searches

Articles (20)

Neural cues differentially modulate colorectal cancer cell behavior depending on patients’ genomic background

Circulating tumor DNA-guided de-escalation or escalation of adjuvant therapy in high-risk stage II and stage III colon cancer: the phase 2 PEGASUS trial

Glioblastoma liquid biopsy: Maximizing insights from DNA traces in cerebrospinal fluid and blood plasma

Site-specific DNA double-strand break induces local transcription <i>in cis</i> and protein expression

Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcription

Clinical Actionability of Genes in Gastrointestinal Tumors

Detecting Cancer Early with Ultrasensitive Multimodal Liquid Biopsy

Liquid Biopsy and Challenge of Assay Heterogeneity for Minimal Residual Disease Assessment in Colon Cancer Treatment

Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models

Clinical utility and future perspectives of liquid biopsy in colorectal cancer

Correction: Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II–III colon cancer (Clinical and Experimental Medicine, (2025), 25, 1, (222), 10.1007/s10238-025-01762-4)

Preoperative ctDNA retains prognostic relevance beyond postoperative assessment in stage II-III colon cancer

The combination of cisplatin and temozolomide triggers immune surveillance through antigen-dependent and independent mechanisms

Tumor “age” in early-onset colorectal cancer

Transcriptome‐wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer

Mutational signatures of colorectal cancers according to distinct computational workflows

DNA demethylation triggers cell free DNA release in colorectal cancer cells

Mutational Signatures in Colorectal Cancer: Translational Insights, Clinical Applications, and Limitations

Immune surveillance of chemotherapy-induced mutant subclones in CRC

KRAS pharmacological blockade elicits tumoral homologous recombination deficiency exploitable with PARP inhibitors

Collaborators (7)

Giorgio Patelli

Mariangela Russo

veerle melotte

Valeria Pessei

Sabrina ARENA

SARA LAGO

Alberto Bardelli

Make your next move.